Back to Search
Start Over
Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: Impact of the linker moiety and unnatural amino acids on M 2 R selectivity.
- Source :
-
European journal of medicinal chemistry [Eur J Med Chem] 2021 Mar 05; Vol. 213, pp. 113159. Date of Electronic Publication: 2021 Jan 13. - Publication Year :
- 2021
-
Abstract
- The family of human muscarinic acetylcholine receptors (MRs) is characterized by a high sequence homology among the five subtypes (M <subscript>1</subscript> R-M <subscript>5</subscript> R), being the reason for a lack of subtype selective MR ligands. In continuation of our work on dualsteric dibenzodiazepinone-type M <subscript>2</subscript> R antagonists, a series of M <subscript>2</subscript> R ligands containing a dibenzodiazepinone pharmacophore linked to small basic peptides was synthesized (64 compounds). The linker moiety was varied with respect to length, number of basic nitrogens (0-2) and flexibility. Besides proteinogenic basic amino acids (Lys, Arg), shorter homologues of Lys and Arg, containing three and two methylene groups, respectively, as well as D-configured amino acids were incorporated. The type of linker had a marked impact on M <subscript>2</subscript> R affinity and also effected M <subscript>2</subscript> R selectivity. In contrast, the structure of the basic peptide rather determined M <subscript>2</subscript> R selectivity than M <subscript>2</subscript> R affinity. For example, the most M <subscript>2</subscript> R selective compound (UR-CG188, 89) with picomolar M <subscript>2</subscript> R affinity (pK <subscript>i</subscript> 9.60), exhibited a higher M <subscript>2</subscript> R selectivity (ratio of K <subscript>i</subscript> M <subscript>1</subscript> R/M <subscript>2</subscript> R/M <subscript>3</subscript> R/M <subscript>4</subscript> R/M <subscript>5</subscript> R: 110:1:5200:55:2300) compared to the vast majority of reported M <subscript>2</subscript> R preferring MR ligands. For selected ligands, M <subscript>2</subscript> R antagonism was confirmed in a M <subscript>2</subscript> R miniG protein recruitment assay.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2021 Elsevier Masson SAS. All rights reserved.)
- Subjects :
- Amino Acids metabolism
Animals
Benzodiazepinones chemical synthesis
Benzodiazepinones chemistry
Cells, Cultured
Dose-Response Relationship, Drug
Humans
Molecular Docking Simulation
Molecular Structure
Muscarinic Antagonists chemical synthesis
Muscarinic Antagonists chemistry
Peptides chemistry
Receptor, Muscarinic M2 metabolism
Structure-Activity Relationship
Amino Acids antagonists & inhibitors
Benzodiazepinones pharmacology
Muscarinic Antagonists pharmacology
Peptides pharmacology
Receptor, Muscarinic M2 antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1768-3254
- Volume :
- 213
- Database :
- MEDLINE
- Journal :
- European journal of medicinal chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 33571911
- Full Text :
- https://doi.org/10.1016/j.ejmech.2021.113159